1-6 of 6
Mohammad Bakr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pure Red Cell Aplasia after ABO Incompatible Hematopoietic Stem Cell Transplantation Successfully Treated with Daratumumab: A Case Report

Amaal Gulied, Afraa Mustafa Sulieman Fadul, Sharon Jacob, Dina Sameh Soliman, Ibrahim Ganwo, Amna Gameil, Anas Ahmad Hamad, Mohammad Bakr, Javid Gaziev
Journal: Blood
Blood (2024) 144 (Supplement 1): 7406.
https://doi.org/10.1182/blood-2024-211805
Published: 2024
Journal Articles

Experience of Plerixafor Use for Autologous Stem Cell Mobilization in Qatar: A Single Center Experience

Amaal Gulied, Farah Imadeldeen Jibril, Rola Ghasoub, Aya Alasmar, Yahya Mulikandathil, Afraa Mustafa Sulieman Fadul, Amna Gameil, Manal Yaghmour, Wedad Saleem, Fabio Culurgioni, Saloua Hmissi, Shereen Elazzazy, Anas Ahmad Hamad, Javid Gaziev, Mohammad Bakr
Journal: Blood
Blood (2024) 144 (Supplement 1): 7123.
https://doi.org/10.1182/blood-2024-212076
Published: 2024
Journal Articles

A Comparison of Different Venous Thromboembolism Prediction Scoring Systems in Newly Diagnosed Multiple Myeloma in an Arabic Population

Ghasoub Rola, Hesham Elsabah, Layaly Bakir, Maria Benkhadra, Liam Fernyhough, Awni Alshurafa, Salma Mustafa, Rajvir Singh, Honar Cherif, Mohammad Bakr
Journal: Blood
Blood (2024) 144 (Supplement 1): 7719.
https://doi.org/10.1182/blood-2024-204728
Published: 2024
Journal Articles

Clinically Significant CMV Infection in Allogeneic Stem-Cell Transplant Recipients: A Single Center Experience

Amaal Gulied, Aya Alasmar, Mohammad Bakr, Hawra Shawayli, Rola Ghasoub, Afraa Mustafa Sulieman Fadul, Amna Gameil, Deena SIDEEG Mudawi, Anas Ahmad Hamad, Javid Gaziev
Journal: Blood
Blood (2023) 142 (Supplement 1): 6986.
https://doi.org/10.1182/blood-2023-189903
Published: 2023
Journal Articles

Trisomy 8 Remains An Intermediate Cytogenetic Risk Factor in Patients with Acute Myeloid Leukemia (AML) Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Mohammad Bakr, M.D., Khalid Ibrahim, M.D., Fazal Hussain, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4900.
https://doi.org/10.1182/blood.V118.21.4900.4900
Published: 2011
Journal Articles

Rearrangements of 12p in Acute Myeloid Leukemia (AML) Remain a Significant Adverse Prognostic Marker When Patients Are Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Wahiba Chebbo, M.D., Khalid Ibrahim, M.D., Mohammad Bakr, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4464.
https://doi.org/10.1182/blood.V118.21.4464.4464
Published: 2011